Novel Test Detects Leftover Cancer DNA in the Blood
Novel Test Detects Leftover Cancer DNA in the Blood by Angela Mohan on April 30, 2021 at 2:59 PM Tumor-uninformed test detects the residual or leftover cancer DNA circulating in the blood of patients following treatment. Guardant Reveal test developed by precision oncology company Guardant Health, is "tumor-uninformed". It doesn't require knowing mutations that were present in the patient's tumor. "The use of ctDNA, which is a type of 'liquid biopsy', is a powerful prognostic tool to detect residual disease, and many prospective trials are under way in the United States, E...
Source: medindia.net